Rhythm Pharmaceuticals, Inc. - Common Stock — 현금 흐름 (NASDAQ:RYTM) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -121.98 M-146 M-173.43 M-136.16 M-113.88 M-115.67 M -119.51 M 투자 활동으로 인한 현금 158.53 M-62.16 M28.03 M-5.67 M-48.17 M-137.15 M -104.91 M 재무활동으로 인한 현금 2.01 M166.48 M213.83 M74.37 M191.24 M217.96 M 180.06 M 잉여 현금 흐름 -121.98 M-146 M-173.43 M-136.16 M-113.88 M-156.63 M -119.51 M

뉴스

Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results - Rhythm Pharmaceutical

Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2026 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth

Analysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out for

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24

Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat'

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Rhythm Pharmaceuticals Misses The Beat In Obesity, But There's A Caveat